FDA Inspection 1168570 — Oklahoma Blood Institute Texas Blood Institute
The FDA completed an inspection of Oklahoma Blood Institute Texas Blood Institute on April 22, 2022 in Wichita Falls, TX. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- April 22, 2022
- Fiscal Year
- 2022
- Product Type
- Biologics
- Project Area
- Blood and Blood Products
- Location
- Wichita Falls, TX (United States)